We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,257.00
Bid: 3,255.00
Ask: 3,257.00
Change: -15.00 (-0.46%)
Spread: 2.00 (0.061%)
Open: 3,281.00
High: 3,296.00
Low: 3,256.00
Prev. Close: 3,272.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian to acquire Illion in ANZ

4 Apr 2024 18:00

RNS Number : 4039J
Experian plc
04 April 2024
 

 

news release

 

 

EXPERIAN TO ACQUIRE ILLION IN AUSTRALIA AND NEW ZEALAND

 

4 April 2024 - Experian, the global information services company, is pleased to announce that it has signed an agreement to acquire illion, one of the leading consumer and commercial credit bureaus in Australia and New Zealand.

 

Brian Cassin, Chief Executive Officer said:

"We are delighted to announce that Experian has entered into an agreement to acquire illion, a highly complementary business to Experian in Australia and New Zealand (A/NZ), which will enhance the competitive dynamics in this important market. This marks a pivotal step in our longstanding commitment to the region and reinforces our dedication to delivering exceptional value and more choice to clients in A/NZ."

 

Overview and Strategic Rationale

Established in 1986 in Australia, illion is a bureau provider of consumer credit reporting, commercial credit reporting, and identity and verification solutions in Australia and New Zealand.

 

Our strategy in EMEA and Asia Pacific is to focus on markets where we have a clear opportunity to operate at scale and deliver innovation-led growth. Experian has successfully operated in A/NZ for over 30 years, serving lending and other institutions with decisioning software, open data and data quality services, as well as consumer bureau services. Australia is currently Experian's fifth largest country of operation by revenue.

 

The Australian lending market, like many of our developed markets, is on a journey to help widen access to credit, lower lending costs and improve digital banking services for consumers and businesses. A series of regulatory reforms in Australia have introduced comprehensive (positive) data and open data services and have widened the array of data assets, scores and analytical insights being adopted by banks and other institutions. This has enhanced appetite for analytical tools and data-driven services, expanding our addressable market opportunity.

 

The acquisition of illion will enable Experian to make full use of this opportunity and offer enhanced choice in A/NZ by providing a meaningful competitive alternative to help businesses accelerate the adoption of digital services. It is highly complementary and synergistic to Experian A/NZ, the combination of which would present a more complete service for clients, adding depth in consumer bureau services, an attractive position in commercial credit bureau services as well as capabilities in identity management solutions. This compares to Experian's strengths in analytical product capability, decisioning software and certain open banking solutions.

 

More businesses in A/NZ will benefit from Experian's leading global platforms to speed up the process of credit granting, enhance digital experiences for users, reduce fraudulent exposure and improve efficiency in banking and other sectors. Experian will be well positioned to introduce more innovation in Australia through capabilities such as the Experian Ascend unified platform, which encompasses Experian's sophisticated analytics, and our PowerCurve decisioning suite.

 

Financial information

The acquisition of 100% of illion is for a total consideration of up to A$820m (c.US$532m*), payable on completion of the transaction and to be funded from Experian's existing cash resources. The acquisition is subject to regulatory review by the competition authority in Australia which we anticipate will conclude in the second half of calendar year 2024. In the first full year of ownership we expect the acquisition to add revenues of c. A$175m and Benchmark EBITDA of c. A$65m. This compares to Experian revenues in A/NZ which are expected to be c. A$115m in FY24.

 

* AUS$/US$ spot exchange rate of 1.54 as at 3 April 2024 

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

 

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 22,400 people operating across 32 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. With corporate headquarters in Dublin, Ireland, we are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQQZLFBZZLZBBK
Date   Source Headline
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.